PBLCX
Price
$43.53
Change
+$0.22 (+0.51%)
Updated
Nov 26 closing price
Net Assets
10.41B
RGAHX
Price
$87.57
Change
+$0.76 (+0.88%)
Updated
Nov 26 closing price
Net Assets
337.93B
Interact to see
Advertisement

PBLCX vs RGAHX

Header iconPBLCX vs RGAHX Comparison
Open Charts PBLCX vs RGAHXBanner chart's image
Principal Blue Chip C
Price$43.53
Change+$0.22 (+0.51%)
VolumeN/A
Net Assets10.41B
American Funds Growth Fund of Amer R5E
Price$87.57
Change+$0.76 (+0.88%)
VolumeN/A
Net Assets337.93B
PBLCX vs RGAHX Comparison Chart in %
View a ticker or compare two or three
VS
PBLCX vs. RGAHX commentary
Nov 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBLCX is a Buy and RGAHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 338B vs. PBLCX (10.4B). RGAHX pays higher dividends than PBLCX: RGAHX (0.44) vs PBLCX (0.00). PBLCX was incepted earlier than RGAHX: PBLCX (12 years) vs RGAHX (10 years). PBLCX (1.69) is less costly to investors than RGAHX (0.44). RGAHX is a more actively managed with annual turnover of: 25.00 vs. PBLCX (14.70). RGAHX has a lower initial minimum investment than PBLCX: RGAHX (250) vs PBLCX (1000). RGAHX annual gain was more profitable for investors over the last year : 8.21 vs. PBLCX (0.83). RGAHX (34.09) and PBLCX (33.86) have equivalent 5 years return.
PBLCXRGAHXPBLCX / RGAHX
Total Expense Ratio1.660.44377%
Annual Report Gross Expense Ratio1.690.44384%
Fund Existence12 years10 years-
Gain YTD8.47219.24044%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets10.4B338B3%
Annual Yield % from dividends0.000.44-
Returns for 1 year0.838.2110%
Returns for 3 years62.9165.9595%
Returns for 5 years33.8634.0999%
Returns for 10 years173.0993.65185%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LWAY24.440.32
+1.33%
Lifeway Foods
NRIX17.200.20
+1.18%
Nurix Therapeutics
HVIIU10.89N/A
N/A
Hennessy Capital Investmnt Corp VII
FEMY0.99N/A
-0.02%
Femasys
HSIC75.25-0.25
-0.33%
Henry Schein